Live at ViVE: Transforming Life Sciences with Digital Biomarkers—featuring Rich Carter

17/04/2024 29 min Episodio 187
Live at ViVE: Transforming Life Sciences with Digital Biomarkers—featuring Rich Carter

Listen "Live at ViVE: Transforming Life Sciences with Digital Biomarkers—featuring Rich Carter"

Episode Synopsis

How do you know if a particular medicine is working?Traditionally, it takes guesswork on the physician’s part and time to find a drug that works for any given patient.But what if we could leverage digital biomarkers to measure the efficacy of a medication very quickly and course correct as needed?Rich Carter serves as Chief Digital Officer at Eli Lilly, where he oversees the teams focused on innovation, user-centered design and digital health.On this episode of The Beat, Rich joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss the future of drug development and clinical trials.Rich describes what digital transformation means in the context of life sciences, explaining how technology can improve drug discovery and accelerate the timeline from discovery to market.Listen in for examples of the 35 digital biomarkers in development at Lilly and learn how Rich’s team thinks about partnering with both physicians and patients to roll out these new digital resources.Topics Covered3 elements of Rich’s role at Lilly—innovation, design and digital healthWhat digital transformation means in the context of life sciencesHow Lilly Direct is working to simplify the patient experienceWhat we do historically in life sciences that doesn’t make sense anymore (given the technology we have today)The potential for AI to remove bias in the drug discovery spaceRich’s insight on accelerating the discovery-to-market process in life sciencesHow Rich’s team uses ‘old data’ to train predictive AI models and why access to data is one of the biggest challenges in life sciencesUsing digital biomarkers to measure the efficacy of a medicine with diverse populationsHow Rich is inspired by the impact his work has on familiesThe 35 biomarkers in different stages of development at Lilly and what that process look likeHow Lilly’s internal incubation lab partners with other innovators in the healthcare ecosystemPartnering with both patients and physicians to roll out digital resourcesConnect with Rich CarterEli LillyRich on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica ShepherdViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResourcesLilly Direct

More episodes of the podcast The Beat